Recurrent nonhepatic and de novo malignancies after liver transplantation

Transplantation

Volumn 88, Issue 5, 2009, Pages 706-710

  Jain, Ashokkumar ^a,b   Fiaz, Orner ^c   Sheikh, Baber ^b   Sharma, Rajeev ^a   Safadjou, Saman ^a   Kashyap, Randeep ^a   Bryan, Leah ^a   Batzold, Pam ^a   Orloff, Mark ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b TEMPLE UNIVERSITY HOSPITAL   (United States)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

De novo cancers; Guidelines; Hepatocellular carcinoma; Immunosuppression; Liver transplantation; Malignancy

Indexed keywords

ABDOMINAL CANCER; ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER RECURRENCE; CLINICAL ARTICLE; COLORECTAL CANCER; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; OROPHARYNX CANCER; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT CANCER; UTERINE CERVIX CANCER; ADOLESCENT; DISEASE FREE SURVIVAL; FIBROSIS; LIVER DISEASE; LIVER TUMOR; METHODOLOGY; MIDDLE AGED; RECURRENT DISEASE; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; FIBROSIS; HUMANS; LIVER DISEASES; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 70349562386     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181b3918e     Document Type: Article

References (23)

1. Jain A, Reyes J, Kashyap R, et al. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg 2000; 232: 490.
2. Jain A, Reyes J, Kashyap R, et al. What have we learned about primary liver transplantation under tacrolimus immunosuppression? Longterm follow-up of the first 1000 patients. Ann Surg 1999; 230: 441.
3. Jain A, Patil VP, Fung J. Incidence of de novo cancer and lymphoproliferative disorders after liver transplantation in relation to age and duration of follow-up. Liver Transpl 2008; 14: 1406.
4. Aberg F, Pukkala E, Hockerstedt K, et al. Risk of malignant neoplasm after liver transplantation: A population-based study. Liver Transpl 2008; 14: 1428.
5. Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: A population-based study. J Hepatol 2001; 34: 84.
6. Bozorgzadeh A, Orloff M, Abt P, et al. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl 2007; 13:807.
7. Iwatsuki. S, Starzl TE. Role of liver transplantation in the treatment of hepatocellular carcinoma. Semin Surg Oncol 1993; 9: 337.
8. Kauffrnan HM, McBride MA, Cherikh WS, et al. Transplant tumor registry: Donors with central nervous system tumorsl. Transplantation 2002; 73: 579.
9. Morath C, Schwenger V, Schmidt J, et al. Transmission of malignancy with solid organ transplants. Transplantation 2005; 80(1 suppl): S164.
10. Benten D, Sterneck M, Panse J, et al. Low recurrence of preexisting extra hepatic malignancies after liver transplantation. Liver Transpl 2008; 14: 789.
11. Penn I. Post transplantation, de novo tumors in liver allograft recipients. Liver Transpl Surg 1996; 2: 52.
12. Penn I. Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 1997; 2: 14.
13. Penn I. Effect of immunosuppression on preexisting cancers. Transplant Proc 1993; 25(1 Pt 2): 1380.
14. Dousset B, Boudet MJ, Soubrane O, et al. Liver transplantation in patients with preexisting malignancy. Transplant Proc 1995; 27: 1793.
15. Kelly DM, Emre S, Guy SR, et al. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998; 83: 1237.
16. Saigal S, Norris S, Srinivasan P, et al. Successful outcome of orthotopic liver transplantation in patients with preexisting malignant states. Liver Transpl 2001; 7: 11.
17. Fayek S, Moore D, Bortecen KH, et al. Liver transplantation in the setting of extra-hepatic malignancy: Two case reports. Transplant Proc 2007; 39: 3512.
18. Dillon TA, Sullivan M, Schatzlein MH, et al. Cardiac transplantation in patients with preexisting malignancies. Transplantation 1991; 52: 82.
19. Starzl TE, Penn I, Putnam CW, et al. Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev 1971; 7: 112.
20. Gruber SA, Matas AJ. Etiology and pathogenesis of tumors occurring after organ transplantation. Transplant Sci 1994; 4: 87.
21. Matas AJ, Simmons RL, Najarian JS. Chronic antigenic stimulation, herpes virus infection, and cancer in transplant recipients. Lancet 1975; 1: 1277.
22. Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972; 14: 407.
23. Penn I. Evaluation of the candidate with a previous malignancy. Liver Transpl Surg 1996; 2(5 suppl 1): 109.